172 related articles for article (PubMed ID: 36214075)
1. Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment.
Matsuyama T; Takahashi H; Tada H; Chikamatsu K
Am J Rhinol Allergy; 2023 Jan; 37(1):58-64. PubMed ID: 36214075
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
[TBL] [Abstract][Full Text] [Related]
3. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
[TBL] [Abstract][Full Text] [Related]
4. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
[TBL] [Abstract][Full Text] [Related]
5. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
6. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
[TBL] [Abstract][Full Text] [Related]
7. Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps.
Shi LL; Song J; Xiong P; Cao PP; Liao B; Ma J; Zhang YN; Zeng M; Liu Y; Wang H; Cui YH; Huang SK; Liu Z
Am J Respir Crit Care Med; 2014 Sep; 190(6):628-38. PubMed ID: 25117756
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
Jonstam K; Swanson BN; Mannent LP; Cardell LO; Tian N; Wang Y; Zhang D; Fan C; Holtappels G; Hamilton JD; Grabher A; Graham NMH; Pirozzi G; Bachert C
Allergy; 2019 Apr; 74(4):743-752. PubMed ID: 30488542
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps.
Soklic TK; Rijavec M; Silar M; Koren A; Kern I; Hocevar-Boltezar I; Korosec P
Radiol Oncol; 2019 Jul; 53(3):323-330. PubMed ID: 31326962
[TBL] [Abstract][Full Text] [Related]
10. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
[TBL] [Abstract][Full Text] [Related]
11. Type 2 inflammation suppression by T-regulatory cells attenuates the eosinophil recruitment in mucosa of chronic sinusitis.
Chang L; Wang Z; Li S; Chen X; Li X; Zhao J; Lai X; Huang J; Wu X; Huang Z; Bellanti JA; Zheng SG; Zhang G
Clin Sci (Lond); 2020 Jan; 134(2):123-138. PubMed ID: 31922185
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
13. [The role of type 2 innate lymphoid cells in the pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyps].
Geng CL; Xing ZM; Yu LS; Wang M; Yuan XP; Liu Y; Zhang G; Wang ZJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):369-374. PubMed ID: 29764019
[No Abstract] [Full Text] [Related]
14. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
Lee M; Kim DW; Shin HW
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
[TBL] [Abstract][Full Text] [Related]
15. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.
Nagarkar DR; Poposki JA; Tan BK; Comeau MR; Peters AT; Hulse KE; Suh LA; Norton J; Harris KE; Grammer LC; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414
[TBL] [Abstract][Full Text] [Related]
16. Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
Paoletti G; Casini M; Malvezzi L; Pirola F; Russo E; Nappi E; Muci GQ; Montagna C; Messina MR; Ferri S; Racca F; Lamacchia D; Cataldo G; Puggioni F; De Virgilio A; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):457-463. PubMed ID: 38095494
[TBL] [Abstract][Full Text] [Related]
17. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
Pelaia C; Benfante A; Busceti MT; Caiaffa MF; Campisi R; Carpagnano GE; Crimi N; D'Amato M; Foschino Barbaro MP; Maglio A; Minenna E; Nolasco S; Paglino G; Papia F; Pelaia G; Portacci A; Ricciardi L; Scichilone N; Scioscia G; Triggiani M; Valenti G; Vatrella A; Crimi C
Front Immunol; 2023; 14():1121237. PubMed ID: 37063895
[TBL] [Abstract][Full Text] [Related]
18. Type 2 and Type 17 Invariant Natural Killer T Cells Contribute to Local Eosinophilic and Neutrophilic Inflammation and Their Function Is Regulated by Mucosal Microenvironment in Nasal Polyps.
Ye X; Bao Q; Chen H; Meng Q; Li Q; Sun L; Li J; Lei W; Wen W; He W; Jiao L; Fang B; Gao Y; Li C
Front Immunol; 2022; 13():803097. PubMed ID: 35720287
[TBL] [Abstract][Full Text] [Related]
19. Group 2 innate lymphoid cells in nasal polyposis.
Stevens WW; Kato A
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
[TBL] [Abstract][Full Text] [Related]
20. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells.
Ramanathan M; Lee WK; Spannhake EW; Lane AP
Am J Rhinol; 2008; 22(2):115-21. PubMed ID: 18416964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
